Albert J. Sinusas, MD
Yale University School of Medicine
New Haven, CT

Disclosures: Intellectual Property Rights: Atheron LLC, MicroVide, LLC; Consulting Fee: MicroVide, LLC; Research Grant: Siemens, Jubilant DraxImage; Royalty: CRC Press

Bryan D. Young, MD, PhD
Yale University School of Medicine
New Haven, CT

Nothing to disclose

After participating in this activity, learners should be able to achieve the following:

• Learn the principle and protocols for FDG PET imaging of cardiac sarcoidosis
• Understand the interpretation and clinical application of FDG viability imaging
• Become familiar with available tracers for use in cardiac amyloidosis
• Know the clinical application of FDG PET in diagnosis of intracardiac, LVAD, and cardiac electronic device infections